Amarin Corp Plc (AMRN)

[sts66]

Update to that article - DVAX's hepatitis B vaccine Heplisav-B was approved by 12-1 Adcom vote, but FDA approval delayed 3 months because they have to run a post-approval CVOT and FDA needs to review the trial design before formal approval - safety signal of potentially causing MI's:

https://seekingalpha.com/article/4095564-dynavax-important-fda-update

And here in V we have a drug that might PREVENT MI's, is perfectly safe, but FDA delayed expanded indication for what will be 5 yrs because they wanted a pre-approval CVOT - what BS.